New Cancer Drug by Sydney Researchers Brings New Hope to Cancer Patients [VIDEO]
By Reissa Su | August 15, 2013 12:05 PM EST
Researchers in Sydney have reached a breakthrough in developing a new type of cancer drug which would target the tumour cells from the inside. The new cancer drugs were tested in rodents and researchers observed that basic structure of cancer cells were being destroyed.
The Sydney researchers have also tested the new cancer drug in cell cultures. The tests have shown promising results as they proved to be effective in destroying every type of cancer which includes neuroblastomas and other cancers affecting children that are difficult to treat.
Lead researcher in Sydney's University of NSW Peter Gunning said the new cancer drug they developed caused the collapse of the cancer cell at a relatively fast pace. Mr. Gunning likened the destruction of the cancer cell to that of a building collapsing as shown in television news reports.
Mr Gunning called the new cancer drugs as anti-tropomyosins and said these will soon be added to the classes of drugs used in chemotherapy. Sydney researchers are hopeful they have achieved a long sought-after target.
Many scientists have attempted to develop a drug that will attack the structure of cancer cells for years but they have yet to develop something to destroy cancer cells and leave the body's tissues untouched.
Mr Gunning said no one has yet to come up with a cancer drug like the one they had in Sydney. The new cancer drug was designed to target tropomyosin, a type of protein in the cell, and organise the destruction of cancer cells from within its structure.
Other medical research groups have focused on developing cancer medication that worked against actin, a cellular molecule that pairs with another protein. Mr. Gunning said the actin found in cancer cells are almost the same as the ones found in the heart and muscles. The heart may stop beating if drugs targeting the actin are taken.
The findings of the new cancer drug developed by Sydney researchers are published in the Cancer Research journal. Mr. Gunning said the target now is to conduct a trial for neuroblastoma in 2014 using the new cancer drugs.
To contact the editor, e-mail:
Most Popular Slideshows
- Taylor Swift Named Forbes' Second Highest Paid Country Musician [PHOTOS]
- Forever Lost: Indescribable Anguish for Malaysia Airlines MH17 Families, Remains of Some Victims May Never Be Found (PHOTOS)
- Celebrities Who Got Pregnant Using IVF: Busting the Myths About IVF
- PageSix: Beyonce & Jay Z Union is Not About Love, All About Business & the Brand
Join the Conversation
- Richard Norris' Successful Face Transplant Lands Him in GQ Cover [WATCH VIDEOS]
- Breaking Discovery: Industrial Pollution Reached South Pole by 19th Century
- NASA Scientists Advance Understanding of Climate Change With The Help Of IceCube
- These 2 Questions Reveal if You Unwittingly Abuse Alcohol
- First Ever Man-Made Leaf That Could Provide Oxygen During Space Travel: A Breathtaking Leap [Watch Video]
- Freshly Leaked Apple iPad Air 2 Cases Confirm Touch ID Sensor; Release Date, Limited Specs and Price Listed
- Moto X Android 4.4.4 KitKat Update Guide: Schedule and How to Install
- Top 4 Reasons Why iPhone 6 Will Hit Big Soon After its Sept 2014 Release Date
- Top Surprising Features Of iOS 8
- Twin Malaysia Airlines MH370, MH17 Aviation Disasters Create Phobia Among Travellers
- OnePlus One vs. Moto X+1 – Early Specifications, Release Date and Price Faceoff
- 2014 Ebola Outbreak: ‘Out of control… and Can Get Worse'; Asky Airline Stops Flying to Liberia, Sierra Leone; Liberia Closes Schools